🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06492213
Recruiting Observational

The Efficacy and Safety of Pulsed Radiofrequency Combined With Platelet-rich Plasma for Infraorbital Neuralgia

NCT06492213 · tracked via the Priya Life Science China tracker
Sponsor
Beijing Tiantan Hospital
Phase
Observational
Started
2024-07-01
Last updated
2025-02-21

Condition(s) studied

Infraorbital NeuralgiaPlatelet-rich Plasma

Investigational drug(s) / intervention(s)

No interventions

No interventions: It is a observational study to investigate the efficacy and safety of PRP combined PRF on IONa compared to PRF alone.

Study summary

This is a multicenter, prospective, observational, propensity score matching, cohort, and assessor-blinded study designed to compare the effectiveness and safety of PRP injections combined with PRF treatment with PRF alone in patients with IONa who are responded poorly to conventional therapies and are reluctant to receive destructive therapies for seeking a better minimally invasive treatment strategy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: 1. Age between 18 to 75 years; 2. Paroxysmal or persistent stabbing pain in the distribution area of the infraorbital nerve and positive response to diagnostic block (1 ml of 2% lidocaine) prior to treatment; 3. NRS score≥7; 4. Scheduled for PRF treatment for IONa; 5. Signed informed consent. Exclusion Criteria: 1. Platelet count \<105\*109/L, ongoing anticoagulation therapy or antiplatelets treatment, coagulation disorders or bleeding disorders; 2. Severe cardiopulmonary or hepatorenal dysfunction; 3. Infection at the puncture site; . 4. Neuralgia secondary to tissue damage around the infraorbital foramen from causes such as maxillary sinusitis or tumor; 5. History of destructive treatments such as radiofrequency thermocoagulation, chemical ablation, infraorbital neurectomy, infraorbital nerve avulsion, etc; 6. History of mental disorders; 7. History of narcotic drug abuse; 8. Unable to cooperation.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Fang Luo Beijing Beijing Municipality Recruiting

More Beijing Tiantan Hospital trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06492213 on ClinicalTrials.gov ↗ ← All trials in China